Literature DB >> 25599672

Mammalian target of rapamycin pathway mutations cause hemimegalencephaly and focal cortical dysplasia.

Alissa M D'Gama1, Ying Geng, Javier A Couto, Beth Martin, Evan A Boyle, Christopher M LaCoursiere, Amer Hossain, Nicole E Hatem, Brenda J Barry, David J Kwiatkowski, Harry V Vinters, A James Barkovich, Jay Shendure, Gary W Mathern, Christopher A Walsh, Annapurna Poduri.   

Abstract

Focal malformations of cortical development, including focal cortical dysplasia (FCD) and hemimegalencephaly (HME), are important causes of intractable childhood epilepsy. Using targeted and exome sequencing on DNA from resected brain samples and nonbrain samples from 53 patients with FCD or HME, we identified pathogenic germline and mosaic mutations in multiple PI3K/AKT pathway genes in 9 patients, and a likely pathogenic variant in 1 additional patient. Our data confirm the association of DEPDC5 with sporadic FCD but also implicate this gene for the first time in HME. Our findings suggest that modulation of the mammalian target of rapamycin pathway may hold promise for malformation-associated epilepsy.
© 2015 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25599672      PMCID: PMC4471336          DOI: 10.1002/ana.24357

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  22 in total

1.  Preliminary functional assessment and classification of DEPDC5 variants associated with focal epilepsy.

Authors:  Melissa van Kranenburg; Marianne Hoogeveen-Westerveld; Mark Nellist
Journal:  Hum Mutat       Date:  2014-11-27       Impact factor: 4.878

2.  DEPDC5 does it all: shared genetics for diverse epilepsy syndromes.

Authors:  Annapurna Poduri
Journal:  Ann Neurol       Date:  2014-05-08       Impact factor: 10.422

3.  Tuberous sclerosis complex with a single brain lesion on MRI mimicking focal cortical dysplasia.

Authors:  Tugba Hirfanoglu; Ajay Gupta
Journal:  Pediatr Neurol       Date:  2010-05       Impact factor: 3.372

4.  Functional assessment of variants in the TSC1 and TSC2 genes identified in individuals with Tuberous Sclerosis Complex.

Authors:  Marianne Hoogeveen-Westerveld; Marjolein Wentink; Diana van den Heuvel; Melika Mozaffari; Rosemary Ekong; Sue Povey; Johan T den Dunnen; Kay Metcalfe; Stephanie Vallee; Stefan Krueger; JoAnn Bergoffen; Vandana Shashi; Frances Elmslie; David Kwiatkowski; Julian Sampson; Concha Vidales; Jacinta Dzarir; Javier Garcia-Planells; Kira Dies; Anneke Maat-Kievit; Ans van den Ouweland; Dicky Halley; Mark Nellist
Journal:  Hum Mutat       Date:  2011-03-08       Impact factor: 4.878

5.  Analysis of TSC cortical tubers by deep sequencing of TSC1, TSC2 and KRAS demonstrates that small second-hit mutations in these genes are rare events.

Authors:  Wei Qin; Jennifer A Chan; Harry V Vinters; Gary W Mathern; David N Franz; Bruce E Taillon; Pascal Bouffard; David J Kwiatkowski
Journal:  Brain Pathol       Date:  2010-07-13       Impact factor: 6.508

6.  Mutations in mammalian target of rapamycin regulator DEPDC5 cause focal epilepsy with brain malformations.

Authors:  Ingrid E Scheffer; Sarah E Heron; Brigid M Regan; Simone Mandelstam; Douglas E Crompton; Bree L Hodgson; Laura Licchetta; Federica Provini; Francesca Bisulli; Lata Vadlamudi; Jozef Gecz; Alan Connelly; Paolo Tinuper; Michael G Ricos; Samuel F Berkovic; Leanne M Dibbens
Journal:  Ann Neurol       Date:  2014-04-14       Impact factor: 10.422

7.  Focal dysplasia of the cerebral cortex and infantile spasms associated with somatic 1q21.1-q44 duplication including the AKT3 gene.

Authors:  V Conti; M Pantaleo; C Barba; G Baroni; D Mei; A M Buccoliero; S Giglio; F Giordano; S T Baek; J G Gleeson; R Guerrini
Journal:  Clin Genet       Date:  2014-10-07       Impact factor: 4.438

8.  Somatic mutations in cerebral cortical malformations.

Authors:  Saumya S Jamuar; Anh-Thu N Lam; Martin Kircher; Alissa M D'Gama; Jian Wang; Brenda J Barry; Xiaochang Zhang; Robert Sean Hill; Jennifer N Partlow; Aldo Rozzo; Sarah Servattalab; Bhaven K Mehta; Meral Topcu; Dina Amrom; Eva Andermann; Bernard Dan; Elena Parrini; Renzo Guerrini; Ingrid E Scheffer; Samuel F Berkovic; Richard J Leventer; Yiping Shen; Bai Lin Wu; A James Barkovich; Mustafa Sahin; Bernard S Chang; Michael Bamshad; Deborah A Nickerson; Jay Shendure; Annapurna Poduri; Timothy W Yu; Christopher A Walsh
Journal:  N Engl J Med       Date:  2014-08-21       Impact factor: 91.245

9.  Single-cell, genome-wide sequencing identifies clonal somatic copy-number variation in the human brain.

Authors:  Xuyu Cai; Gilad D Evrony; Hillel S Lehmann; Princess C Elhosary; Bhaven K Mehta; Annapurna Poduri; Christopher A Walsh
Journal:  Cell Rep       Date:  2014-08-21       Impact factor: 9.423

10.  Lymphatic and other vascular malformative/overgrowth disorders are caused by somatic mutations in PIK3CA.

Authors:  Valerie L Luks; Nolan Kamitaki; Matthew P Vivero; Wibke Uller; Rashed Rab; Judith V M G Bovée; Kristy L Rialon; Carlos J Guevara; Ahmad I Alomari; Arin K Greene; Steven J Fishman; Harry P W Kozakewich; Reid A Maclellan; John B Mulliken; Reza Rahbar; Samantha A Spencer; Cameron C Trenor; Joseph Upton; David Zurakowski; Jonathan A Perkins; Andrew Kirsh; James T Bennett; William B Dobyns; Kyle C Kurek; Matthew L Warman; Steven A McCarroll; Rudy Murillo
Journal:  J Pediatr       Date:  2015-02-11       Impact factor: 4.406

View more
  82 in total

1.  Genetics of Epilepsy in Clinical Practice.

Authors:  Samuel F Berkovic
Journal:  Epilepsy Curr       Date:  2015 Jul-Aug       Impact factor: 7.500

2.  The mTOR pathway in treatment of epilepsy: a clinical update.

Authors:  Jennifer L Griffith; Michael Wong
Journal:  Future Neurol       Date:  2018-05-29

3.  Somatic Mutations in TSC1 and TSC2 Cause Focal Cortical Dysplasia.

Authors:  Jae Seok Lim; Ramu Gopalappa; Se Hoon Kim; Suresh Ramakrishna; Minji Lee; Woo-Il Kim; Junho Kim; Sang Min Park; Junehawk Lee; Jung-Hwa Oh; Heung Dong Kim; Chang-Hwan Park; Joon Soo Lee; Sangwoo Kim; Dong Seok Kim; Jung Min Han; Hoon-Chul Kang; Hyongbum Henry Kim; Jeong Ho Lee
Journal:  Am J Hum Genet       Date:  2017-02-16       Impact factor: 11.025

Review 4.  The genetics of the epilepsies.

Authors:  Christelle M El Achkar; Heather E Olson; Annapurna Poduri; Phillip L Pearl
Journal:  Curr Neurol Neurosci Rep       Date:  2015-07       Impact factor: 5.081

5.  Chronic mTORC1 inhibition rescues behavioral and biochemical deficits resulting from neuronal Depdc5 loss in mice.

Authors:  Christopher J Yuskaitis; Leigh-Ana Rossitto; Sarika Gurnani; Elizabeth Bainbridge; Annapurna Poduri; Mustafa Sahin
Journal:  Hum Mol Genet       Date:  2019-09-01       Impact factor: 6.150

6.  The enlarging spectrum of focal cortical dysplasias.

Authors:  Peter B Crino
Journal:  Brain       Date:  2015-06       Impact factor: 13.501

Review 7.  New frontiers in modeling tuberous sclerosis with human stem cell-derived neurons and brain organoids.

Authors:  John D Blair; Helen S Bateup
Journal:  Dev Dyn       Date:  2019-05-23       Impact factor: 3.780

8.  Delving Deeper into DEPDC5.

Authors:  Laura A Jansen
Journal:  Epilepsy Curr       Date:  2018 May-Jun       Impact factor: 7.500

9.  Malformations of Cerebral Cortex Development: Molecules and Mechanisms.

Authors:  Gordana Juric-Sekhar; Robert F Hevner
Journal:  Annu Rev Pathol       Date:  2019-01-24       Impact factor: 23.472

10.  Prevention of premature death and seizures in a Depdc5 mouse epilepsy model through inhibition of mTORC1.

Authors:  Lindsay K Klofas; Brittany P Short; Chengwen Zhou; Robert P Carson
Journal:  Hum Mol Genet       Date:  2020-05-28       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.